LITHIUM CARBONATE
LITHIUM · BIPOLAR DISORDER
AHP
Drug class
Lithium
While "lithium" commonly refers to the active monovalent cation ingredient rather than a standalone therapeutic class, the Food and Drug Administration categorizes it under the established pharmacologic class of mood stabilizers. Read more about Lithium
34 drugs in this class 25 manufacturers
Drugs in Lithium
LITHIUM CARBONATE
LITHIUM · BIPOLAR DISORDER
PROFICIENT RX L
LITHIUM CARBONATE
LITHIUM · BIPOLAR DISORDER
BRYANT RANCH PR
LITHIUM CARBONATE
LITHIUM · BIPOLAR DISORDER
PREPAK SYSTEMS,
LITHIUM CITRATE
LITHIUM · BIPOLAR DISORDER
SAPTALIS PHARMA
LITHIUM CITRATE
LITHIUM · BIPOLAR DISORDER
ADVAGEN PHARMA
LITHIUM CARBONATE
LITHIUM · BIPOLAR DISORDER
PD-RX PHARM
LITHIUM CARBONATE ER (lithium carbonate)
LITHIUM · BIPOLAR DISORDER
PD-RX PHARM
LITHIUM CARBONATE ER (lithium carbonate)
LITHIUM · BIPOLAR DISORDER
AHP
Filter & compare in the drug finder →
Opens the drug finder with Lithium preselected. Add indication or manufacturer filters there.
While "lithium" commonly refers to the active monovalent cation ingredient rather than a standalone therapeutic class, the Food and Drug Administration categorizes it under the established pharmacologic class of mood stabilizers.
In clinical therapeutics, lithium salts—primarily lithium carbonate and lithium citrate—exert psychotropic effects by modulating central neurotransmission, inhibiting inositol monophosphatase and glycogen synthase kinase-3, and altering intracellular signaling cascades.
The primary indications are the management of acute manic and mixed episodes and the long-term maintenance treatment of bipolar disorder to prevent relapse, as well as adjunctive therapy in treatment-resistant major depressive disorder.
Due to a narrow therapeutic index, its use requires systematic therapeutic drug monitoring to prevent acute and chronic toxicity.
-
fda.gov
While "lithium" commonly refers to the active monovalent cation ingredient rather than a standalone therapeutic class, the Food and Drug Administration categorizes it under the established pharmacologic class of mood stabilizers
-
fda.gov
While "lithium" commonly refers to the active monovalent cation ingredient rather than a standalone therapeutic class, the Food and Drug Administration categorizes it under the established pharmacologic class of mood stabilizers
-
fda.gov
The primary indications are the management of acute manic and mixed episodes and the long-term maintenance treatment of bipolar disorder to prevent relapse, as well as adjunctive therapy in treatment-resistant major depressive disorder
-
fda.gov
The primary indications are the management of acute manic and mixed episodes and the long-term maintenance treatment of bipolar disorder to prevent relapse, as well as adjunctive therapy in treatment-resistant major depressive disorder
-
medlineplus.gov
The primary indications are the management of acute manic and mixed episodes and the long-term maintenance treatment of bipolar disorder to prevent relapse, as well as adjunctive therapy in treatment-resistant major depressive disorder
-
fda.gov
The primary indications are the management of acute manic and mixed episodes and the long-term maintenance treatment of bipolar disorder to prevent relapse, as well as adjunctive therapy in treatment-resistant major depressive disorder
-
nih.gov
Due to a narrow therapeutic index, its use requires systematic therapeutic drug monitoring to prevent acute and chronic toxicity
-
medlineplus.gov
Due to a narrow therapeutic index, its use requires systematic therapeutic drug monitoring to prevent acute and chronic toxicity
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.